Patent · US Active

Recombinant foot-and-mouth disease virus with reduced immunosuppression activity, and preparation method and use thereof

US11952401B2 · kind B2 · utility

0Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 14, 2021
Grant dateApr 9, 2024
Priority date
Expiry dateFeb 15, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/32171
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure belongs to the technical field of biological products for veterinary medicine, and specifically relates to a recombinant foot-and-mouth disease virus (FMDV) with a reduced immunosuppressive activity, a preparation method and use thereof, and a recombinant vaccine strain. According to the present disclosure, it is firstly discovered that FMDV 3B protein has an immunosuppressive function, and key sites for exerting the immunosuppressive function are found. A recombinant FMDV vaccine strain with a lost immunosuppressive function in FMDV 3B protein is constructed by introducing amino acid mutations into three repeated copies of FMDV 3B protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.